Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration

Laura Conforti, Lucie Janeckova, Diana Wagner, Francesca Mazzola, Lucia Cialabrini, Michele Di Stefano, Giuseppe Orsomando, Giulio Magni, Caterina Bendotti, Neil Smyth, Michael Coleman

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

NAD+ synthesizing enzyme NMNAT1 constitutes most of the sequence of neuroprotective protein WldS, which delays axon degeneration by 10-fold. NMNAT1 activity is necessary but not sufficient for WldS neuroprotection in mice and 70 amino acids at the N-terminus of WldS, derived from polyubiquitination factor Ube4b, enhance axon protection by NMNAT1. NMNAT1 activity can confer neuroprotection when redistributed outside the nucleus or when highly overexpressed in vitro and partially in Drosophila. However, the role of endogenous NMNAT1 in normal axon maintenance and in Wallerian degeneration has not been elucidated yet. To address this question we disrupted the Nmnat1 locus by gene targeting. Homozygous Nmnat1 knockout mice do not survive to birth, indicating that extranuclear NMNAT isoforms cannot compensate for its loss. Heterozygous Nmnat1 knockout mice develop normally and do not show spontaneous neurodegeneration or axon pathology. Wallerian degeneration after sciatic nerve lesion is neither accelerated nor delayed in these mice, consistent with the proposal that other endogenous NMNAT isoforms play a principal role in Wallerian degeneration.

Original languageEnglish
Pages (from-to)2666-2679
Number of pages14
JournalFEBS Journal
Volume278
Issue number15
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Wallerian Degeneration
NAD
Axons
Enzymes
Knockout Mice
Protein Isoforms
Sciatic Neuropathy
Gene Targeting
Pathology
Drosophila
Genes
Maintenance
Parturition
Amino Acids
Proteins
Neuroprotection

Keywords

  • axon
  • Cre-loxP knockout
  • NAD(P)
  • NMNAT
  • Wallerian degeneration

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Conforti, L., Janeckova, L., Wagner, D., Mazzola, F., Cialabrini, L., Di Stefano, M., ... Coleman, M. (2011). Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration. FEBS Journal, 278(15), 2666-2679. https://doi.org/10.1111/j.1742-4658.2011.08193.x

Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration. / Conforti, Laura; Janeckova, Lucie; Wagner, Diana; Mazzola, Francesca; Cialabrini, Lucia; Di Stefano, Michele; Orsomando, Giuseppe; Magni, Giulio; Bendotti, Caterina; Smyth, Neil; Coleman, Michael.

In: FEBS Journal, Vol. 278, No. 15, 08.2011, p. 2666-2679.

Research output: Contribution to journalArticle

Conforti, L, Janeckova, L, Wagner, D, Mazzola, F, Cialabrini, L, Di Stefano, M, Orsomando, G, Magni, G, Bendotti, C, Smyth, N & Coleman, M 2011, 'Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration', FEBS Journal, vol. 278, no. 15, pp. 2666-2679. https://doi.org/10.1111/j.1742-4658.2011.08193.x
Conforti L, Janeckova L, Wagner D, Mazzola F, Cialabrini L, Di Stefano M et al. Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration. FEBS Journal. 2011 Aug;278(15):2666-2679. https://doi.org/10.1111/j.1742-4658.2011.08193.x
Conforti, Laura ; Janeckova, Lucie ; Wagner, Diana ; Mazzola, Francesca ; Cialabrini, Lucia ; Di Stefano, Michele ; Orsomando, Giuseppe ; Magni, Giulio ; Bendotti, Caterina ; Smyth, Neil ; Coleman, Michael. / Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration. In: FEBS Journal. 2011 ; Vol. 278, No. 15. pp. 2666-2679.
@article{f9769095c89c46bd8ed377d23b5d8ef3,
title = "Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration",
abstract = "NAD+ synthesizing enzyme NMNAT1 constitutes most of the sequence of neuroprotective protein WldS, which delays axon degeneration by 10-fold. NMNAT1 activity is necessary but not sufficient for WldS neuroprotection in mice and 70 amino acids at the N-terminus of WldS, derived from polyubiquitination factor Ube4b, enhance axon protection by NMNAT1. NMNAT1 activity can confer neuroprotection when redistributed outside the nucleus or when highly overexpressed in vitro and partially in Drosophila. However, the role of endogenous NMNAT1 in normal axon maintenance and in Wallerian degeneration has not been elucidated yet. To address this question we disrupted the Nmnat1 locus by gene targeting. Homozygous Nmnat1 knockout mice do not survive to birth, indicating that extranuclear NMNAT isoforms cannot compensate for its loss. Heterozygous Nmnat1 knockout mice develop normally and do not show spontaneous neurodegeneration or axon pathology. Wallerian degeneration after sciatic nerve lesion is neither accelerated nor delayed in these mice, consistent with the proposal that other endogenous NMNAT isoforms play a principal role in Wallerian degeneration.",
keywords = "axon, Cre-loxP knockout, NAD(P), NMNAT, Wallerian degeneration",
author = "Laura Conforti and Lucie Janeckova and Diana Wagner and Francesca Mazzola and Lucia Cialabrini and {Di Stefano}, Michele and Giuseppe Orsomando and Giulio Magni and Caterina Bendotti and Neil Smyth and Michael Coleman",
year = "2011",
month = "8",
doi = "10.1111/j.1742-4658.2011.08193.x",
language = "English",
volume = "278",
pages = "2666--2679",
journal = "FEBS Journal",
issn = "1742-464X",
publisher = "Wiley-Blackwell",
number = "15",

}

TY - JOUR

T1 - Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration

AU - Conforti, Laura

AU - Janeckova, Lucie

AU - Wagner, Diana

AU - Mazzola, Francesca

AU - Cialabrini, Lucia

AU - Di Stefano, Michele

AU - Orsomando, Giuseppe

AU - Magni, Giulio

AU - Bendotti, Caterina

AU - Smyth, Neil

AU - Coleman, Michael

PY - 2011/8

Y1 - 2011/8

N2 - NAD+ synthesizing enzyme NMNAT1 constitutes most of the sequence of neuroprotective protein WldS, which delays axon degeneration by 10-fold. NMNAT1 activity is necessary but not sufficient for WldS neuroprotection in mice and 70 amino acids at the N-terminus of WldS, derived from polyubiquitination factor Ube4b, enhance axon protection by NMNAT1. NMNAT1 activity can confer neuroprotection when redistributed outside the nucleus or when highly overexpressed in vitro and partially in Drosophila. However, the role of endogenous NMNAT1 in normal axon maintenance and in Wallerian degeneration has not been elucidated yet. To address this question we disrupted the Nmnat1 locus by gene targeting. Homozygous Nmnat1 knockout mice do not survive to birth, indicating that extranuclear NMNAT isoforms cannot compensate for its loss. Heterozygous Nmnat1 knockout mice develop normally and do not show spontaneous neurodegeneration or axon pathology. Wallerian degeneration after sciatic nerve lesion is neither accelerated nor delayed in these mice, consistent with the proposal that other endogenous NMNAT isoforms play a principal role in Wallerian degeneration.

AB - NAD+ synthesizing enzyme NMNAT1 constitutes most of the sequence of neuroprotective protein WldS, which delays axon degeneration by 10-fold. NMNAT1 activity is necessary but not sufficient for WldS neuroprotection in mice and 70 amino acids at the N-terminus of WldS, derived from polyubiquitination factor Ube4b, enhance axon protection by NMNAT1. NMNAT1 activity can confer neuroprotection when redistributed outside the nucleus or when highly overexpressed in vitro and partially in Drosophila. However, the role of endogenous NMNAT1 in normal axon maintenance and in Wallerian degeneration has not been elucidated yet. To address this question we disrupted the Nmnat1 locus by gene targeting. Homozygous Nmnat1 knockout mice do not survive to birth, indicating that extranuclear NMNAT isoforms cannot compensate for its loss. Heterozygous Nmnat1 knockout mice develop normally and do not show spontaneous neurodegeneration or axon pathology. Wallerian degeneration after sciatic nerve lesion is neither accelerated nor delayed in these mice, consistent with the proposal that other endogenous NMNAT isoforms play a principal role in Wallerian degeneration.

KW - axon

KW - Cre-loxP knockout

KW - NAD(P)

KW - NMNAT

KW - Wallerian degeneration

UR - http://www.scopus.com/inward/record.url?scp=79960605733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960605733&partnerID=8YFLogxK

U2 - 10.1111/j.1742-4658.2011.08193.x

DO - 10.1111/j.1742-4658.2011.08193.x

M3 - Article

VL - 278

SP - 2666

EP - 2679

JO - FEBS Journal

JF - FEBS Journal

SN - 1742-464X

IS - 15

ER -